Condition: ADHD · Sponsor: Hebrew University of Jerusalem
The goal of this clinical trial is to examine the effectiveness of Cognitive-Functional Remote Group intervention (Cog-Fun RG). The main questions of this study are 1. will participants demonstrate improvements in their executive functioning and quality of life after receiving the intervention, compared to waitlist controls. In addition, the investigators will examine if the waitlist group will demonstrate similar gains in these outcomes after receiving the same intervention. the investigators will compare between the intervention group to the waiting list group to examine the effect of the intervention. The participants will be allocated into two groups: an intervention group and a waiting list group. The intervention group will receive the the Cog-Fun RG intervention, which includes 21 weekly group sessions, each lasting 90 minutes. the participants will be required to complete questionnaires at several time points: pre-post the intervention, as well as three months, six months, and one year after the intervention. The waiting list controls will be required to complete questionnaires at several time points: pre-post waiting period, and then after the intervention, as well as three months, six months, and one year after the intervention.
This description comes directly from the study's public registry record.
Adina Prof. Maeir, PhD · 972 546205081 · adina.maeir@mail.hui.ac.il
Ruthi Dr Traub Bar Ilan, PhD · 972 544990500 · ruthie.traub@mail.huji.ac.il.il
Always discuss trial participation with your own doctor first.
| Hebrew University | Jerusalem, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06639139